CIK 0001213037 · Non-accelerated filer<br>Smaller reporting company
Cardiff Oncology, Inc.
Sign in to watch- Ticker
- CRDF
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 272004382
- Phone
- 858-952-7570
- Business address
- 11055 FLINTKOTE AVENUE, SAN DIEGO, CA, 92121
- Former names
- Trovagene, Inc., TrovaGene Inc., XENOMICS INC, USED KAR PARTS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-11-23 | Kelemen Vicki Exec. VP and COO | Option exercise · Stock Options | −35,321 | $2.48 | $88K | 70,641 |
| 2020-09-16 | PACE GARY W Director | Purchase | +1,700 | $5.69 | $10K | 449,461 |
| 2020-09-16 | PACE GARY W Director | Purchase | +850 | $5.71 | $5K | 450,311 |
| 2020-06-17 | PACE GARY W Director | Grant or award · Stock Options | +28,858 | 40,774 |
Page 8 of 8 · 144 trades